Disposable Diabetes Lancets Companies, Corporate Milestones, Corporate Growth and Development Strategy, Mergers and Acquisitions (M&A), Intellectual Property (IP) Portfolio Management, Market Trends Analysis, Leadership Alignment with Trends

Disposable Diabetes Lancets Companies and Competitive Landscape

The disposable diabetes lancets market size was estimated at US$ 1.19 billion in 2023 and is projected to grow to US$ 1.9 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.33% from 2024 to 2034.

Top Companies in the Disposable Diabetes Lancets:

• A. Menarini Diagnostics
• Acon Diabetes Care
• AdvaCare Pharma
• Arkray Healthcare Pvt. Ltd.
• BioCare Corporation
• CVS Pharmacy
• Drawbridge Health
• Genteel
• Hoffman La-Roche Ltd.
• Owen Mumford
• Pip Diabetes
• SD Biosensor Healthcare Pvt. Ltd.

Recent Developments in the Disposable Diabetes Lancets Market

• In April 2024, Drawbridge Health announced that they received 510(k) clearance from the US FDA for its advanced at-home blood sampling device, NanoDrop Lancet, for OTC use. NanoDrop Lancet is the US FDA-approved OTC blood-lancing device labeled for the upper arm.
• In March 2023, Pip Diabetes developed painless, single-use lancets to help customers get a clean and painless blood sample. The lancets are precision-engineered to ensure proper needle gauge and depth and to minimize vibration, eliminating pain from the fingerstick.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com